LAURA MENDOZA: Open Payments
NPI 1043720782 · WINTER GARDEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 29 payments from 11 companies in 2025. Trend: 2023 $702 · 2024 $676 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $144 |
| ABBVIE INC. | 5 | $91 |
| Lilly USA, LLC | 4 | $77 |
| Astellas Pharma US Inc | 3 | $64 |
| PFIZER INC. | 3 | $63 |
| Axsome Therapeutics, Inc. | 2 | $56 |
| Abbott Laboratories | 2 | $47 |
| Esperion Therapeutics, Inc. | 2 | $29 |
| Exact Sciences Corporation | 1 | $26 |
| Novo Nordisk Inc | 1 | $25 |
Products named: BREZTRI, Veozah, ELIQUIS, MOUNJARO, Auvelity, FREESTYLE LIBRE 3, FARXIGA, UBRELVY.
Industry payments across FL — which companies pay providers there.
